1. Home
  2. MGTX vs CYBN Comparison

MGTX vs CYBN Comparison

Compare MGTX & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MGTX
    SELLHOLDBUYas of 8 hours ago
  • CYBN
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • MGTX 2015
  • CYBN 2019
  • Country
  • MGTX United States
  • CYBN Canada
  • Employees
  • MGTX N/A
  • CYBN N/A
  • Industry
  • MGTX Biotechnology: Biological Products (No Diagnostic Substances)
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • MGTX Health Care
  • CYBN Health Care
  • Exchange
  • MGTX Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • MGTX 479.9M
  • CYBN 177.9M
  • IPO Year
  • MGTX N/A
  • CYBN N/A
  • Fundamental
  • Price
  • MGTX $6.04
  • CYBN $10.01
  • Analyst Decision
  • MGTX Strong Buy
  • CYBN Strong Buy
  • Analyst Count
  • MGTX 2
  • CYBN 3
  • Target Price
  • MGTX $23.50
  • CYBN $138.00
  • AVG Volume (30 Days)
  • MGTX 337.1K
  • CYBN 216.0K
  • Earning Date
  • MGTX 03-13-2025
  • CYBN 02-12-2025
  • Dividend Yield
  • MGTX N/A
  • CYBN N/A
  • EPS Growth
  • MGTX N/A
  • CYBN N/A
  • EPS
  • MGTX N/A
  • CYBN N/A
  • Revenue
  • MGTX $13,929,000.00
  • CYBN N/A
  • Revenue This Year
  • MGTX N/A
  • CYBN N/A
  • Revenue Next Year
  • MGTX $1,391.84
  • CYBN N/A
  • P/E Ratio
  • MGTX N/A
  • CYBN N/A
  • Revenue Growth
  • MGTX 108.24
  • CYBN N/A
  • 52 Week Low
  • MGTX $3.85
  • CYBN $6.50
  • 52 Week High
  • MGTX $7.37
  • CYBN $19.84
  • Technical
  • Relative Strength Index (RSI)
  • MGTX 48.18
  • CYBN 54.97
  • Support Level
  • MGTX $5.66
  • CYBN $8.83
  • Resistance Level
  • MGTX $6.65
  • CYBN $9.41
  • Average True Range (ATR)
  • MGTX 0.41
  • CYBN 0.59
  • MACD
  • MGTX 0.00
  • CYBN 0.07
  • Stochastic Oscillator
  • MGTX 41.51
  • CYBN 65.80

Stock Price Comparison Chart: MGTX vs CYBN

MGTX
CYBN
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025024681012141618202224MGTX VS CYBN

About MGTX MeiraGTx Holdings plc

MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use